As society continues to address the complexities of mental health issues, the therapeutic use of psychedelics is becoming more widely
At MAC Clinical Research, we take our Corporate Social Responsibility (CSR) very seriously. Our commitment is multifaceted and extends throughout
As we come closer to the end of the year, I want to take the opportunity to reflect on 2023
At MAC, we consistently prioritise subject diversity in the trials we run and manage. We highly value this commitment and,
With insight from Dr Abiramy Yogendran Menopause is a natural biological process that marks the end of a woman’s reproductive
Last week we attended the PHUSE EU Connect 2023 conference in Birmingham from 5 to 8 November. The conference was
At the beginning of November, our Vice President of Global Proposals, Jude Warburton attended AusBiotech 2023 in Brisbane, Australia. This
Kariya Pharmaceuticals has received approval from the MHRA for their Clinical Trial Application (CTA) related to their leading Parkinson’s drug
Alzheimer’s Disease (AD) is a complex and pervasive condition that affects the central nervous system (CNS) of millions of lives
Psoriasis is a chronic skin disease that affects millions of people worldwide causing uncomfortable and itchy scaly patches primarily on
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
